April 2022 PMID 34143369

The Effect of Oral Magnesium Supplementation on Inflammatory Biomarkers in Adults: A Comprehensive Systematic Review and Dose-response Meta-analysis of Randomized Clinical Trials.

Sepide Talebi, Maryam Miraghajani, Reza Hosseini, Hamed Mohammadi

Download social card

Mentions

Peak: 3 in May 2025

across 2 sources since Jun 2021

Extended reach

501,245

potential audience

Total likes

10,821

Video views

494,304

Mentions per month

Jun 2021 – May 2025

Where it's discussed

YouTube3 videos
X / Twitter2 posts

AI synopsis

What people are saying

Discussions include mentions of the comprehensive nature of the systematic review and its focus on inflammation markers like CRP, IL6, and TNF, with some commenters questioning the significance of results despite the detailed methodology. The tone is mostly informational, with phrases like 'no significant effects' and 'comprehensive analysis,' reflecting cautious acknowledgment rather than strong endorsement or critique.

AgreementNeither agree nor disagree

The discussions show neutral or mixed reactions to the findings, with some postings mentioning support or neutrality towards the research conclusions.

InterestModerate interest

Most posts demonstrate a modest interest, with some expressing curiosity or noting the relevance of the findings, but not overwhelmingly so.

EngagementModerate engagement

Users engage by referencing the research methods and implications, but without deep dives or critical analysis, indicating a surface-level engagement.

ImpactNeutral impact

The overall perception of the study's impact appears modest, with no posts emphasizing groundbreaking changes or significant influence on practice or opinion.

Abstract in brief

The systematic review analyzed 18 studies with 927 adults to see if taking magnesium supplements affects inflammation markers like CRP, IL6, and TNF, but found no significant effects.
The research used multiple databases up to December 2020 and assessed study quality, also performing subgroup analyses to understand variability.
Overall, the study concluded that oral magnesium does not significantly alter these inflammation biomarkers, and increasing dosage or duration doesn't change this outcome.]

Read the full abstract